Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier

Invasive fungal diseases have increased many fold over the past 50 years. Current treatment regimens typically require prolonged administration of antifungal medications that can have significant toxicity. Moreover, our present potent antifungal armamentarium fails to eradicate fungal pathogens from...

Full description

Saved in:
Bibliographic Details
Superior document:Frontiers Research Topics
:
Year of Publication:2017
Language:English
Series:Frontiers Research Topics
Physical Description:1 electronic resource (183 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02213nam-a2200421z--4500
001 993543792804498
005 20231214133246.0
006 m o d
007 cr|mn|---annan
008 202102s2017 xx |||||o ||| 0|eng d
035 |a (CKB)4100000002484751 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/61823 
035 |a (EXLCZ)994100000002484751 
041 0 |a eng 
100 1 |a Carlos P. Taborda  |4 auth 
245 1 0 |a Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi: Updates in the New Frontier 
246 |a Vaccines, Immunotherapy and New Antifungal Therapy Against Fungi 
246 |a Vaccines; Immunotherapy and New Antifungal Therapy Against Fungi 
260 |b Frontiers Media SA  |c 2017 
300 |a 1 electronic resource (183 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Frontiers Research Topics 
520 |a Invasive fungal diseases have increased many fold over the past 50 years. Current treatment regimens typically require prolonged administration of antifungal medications that can have significant toxicity. Moreover, our present potent antifungal armamentarium fails to eradicate fungal pathogens from certain compromised hosts. Additionally, invasive fungal diseases continue to have unacceptably high mortality rates. A growing body of work has focused on the utility of vaccines and/or immunotherapy as a powerful tool in combating mycoses, either for the active treatment, as an adjuvant, or in the prevention of specific fungal pathogens. Also, it is growing the interest over new drugs development as second choice for treatment when traditional chemotherapy fail. This Research Topic will detail the exciting progress in developing vaccines, immunotherapy and new drugs for fungi. 
546 |a English 
653 |a antifugal drugs 
653 |a vaccine 
653 |a peptide 
653 |a antibody 
653 |a virulence 
653 |a fungi 
653 |a immunotherapy 
653 |a humanized antibody 
653 |a mycosis 
653 |a cell biology 
776 |z 2-88945-327-8 
700 1 |a Joshua D. Nosanchuk  |4 auth 
906 |a BOOK 
ADM |b 2023-12-15 05:48:08 Europe/Vienna  |f system  |c marc21  |a 2018-03-10 17:16:05 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337400400004498&Force_direct=true  |Z 5337400400004498  |b Available  |8 5337400400004498